Search

Search Constraints

You searched for: Author/Creator He, YanLing

Search Results

1. An evaluation of a supratherapeutic dose of inclisiran on cardiac repolarization in healthy volunteers: A phase I, randomized study. Issue 11 (5th October 2022)

2. First‐in‐human clinical trial to assess pharmacokinetics, pharmacodynamics, safety, and tolerability of iscalimab, an anti‐CD40 monoclonal antibody. Issue 2 (6th December 2019)

7. Translational Population‐Pharmacodynamic Modeling of a Novel Long‐Acting siRNA Therapy, Inclisiran, for the Treatment of Hypercholesterolemia. Issue 2 (14th November 2022)